EPFL’s chip-link technology provider has added more than $36m to a Swisscom-backed round that now totals $92.3m, taking its total funding to almost $133m.

The CreditEase-backed, data-focused wealth manager has now raised a total of about $325m, with WestCap's Strategic Operator Fund leading its latest round.

Berkeley Catalyst Fund-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.

Pfizer Ventures and Chiesi Ventures-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.

The biomanufacturer has now raised at least $103m altogether, with BBGI Public Company leading its series B round.

Kevin Leslie, associate director of VCU Ventures, has moved on to become executive director of Hampton Roads Biomedical Research Consortium.

Nereid Therapeutics will advance research by Clifford Brangwynne of Princeton University following its launch with a $50m series A round from Apple Tree Partners.

NAC International led a series A round for nuclear waste manager Deep Isolation following an initial partnership formed last year.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Recruit, Intel, New York Life, Cisco and Citi-backed enterprise AI platform developer increased its valuation to $2.7bn and its overall funding to about $500m.